½ÃÀ庸°í¼­
»óǰÄÚµå
1649514

¼¼°èÀÇ ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ®(LAMS) ½ÃÀå : ¿¹Ãø(2025-2030³â)

Lumen Apposing Metal Stent Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 148 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀåÀº 2025³â 36¾ï 7,800¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, CAGR 5.12%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â±îÁö´Â 47¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ®(LAMS)´Â ³»½Ã°æ ÀÎÅͺ¥¼ÇÀÇ ¹üÀ§¸¦ È®ÀåÇϵµ·Ï ¼³°èµÈ Ư¼ö ÀåºñÀÔ´Ï´Ù. ´ýº§ÇüÀ¸·Î ¾ÈÀå ±æÀ̰¡ ª´Ù´Â Ư¡À» °¡Áø LAMS´Â ÃéÀå¾× Àú·ùºÎ(PFC)ÀÇ ¹è¼ö ¹× ´Ù¾çÇÑ ¼ÒÈ­°ü Áúȯ¿¡ ´ëÇÑ ´ëÀÀ¿¡ ƯȭÇÏ¿© ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ºÅÙÆ®´Â ÀüÅëÀûÀÎ ½ºÅÙÆ®¿¡ ºñÇØ ƯÈ÷ ¹è¼ö È¿À²¸é¿¡¼­ Å« ÀåÁ¡ÀÌ ÀÖÀ¸¸ç, º® ±«»ç¿Í °°Àº º´¸®Çп¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ LAMS´Â À̵¿ÀÇ À§ÇèÀ» ÁÙÀ̰í ħ½ÀÀû Ä¡·áÀÇ Çʿ伺À» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¼¼°èÀÇ ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀåÀº ÁÖ·Î ¼¼°è ¿°Áõ¼º Àå Áúȯ(IBD)ÀÇ ÀÌȯÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. LAMS´Â ƯÈ÷ Å©·Ðº´°ú °°Àº IBD °ü¸®¿¡¼­ È¿°úÀûÀÎ ¸ð´ÏÅ͸µ°ú Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. À§Àå ÁúȯÀÇ À¯º´·ü »ó½Âµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª, ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀåÀÇ È®´ë´Â ºÎÀÛ¿ëÀÇ °¡´É¼º°ú ÀÌ·¯ÇÑ Á¶Ä¡¿Í °ü·ÃµÈ °í°¡ÀÇ ºñ¿ëÀ¸·Î ÀÎÇØ ¹®Á¦¿¡ Á÷¸éÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀϹÝÀûÀ¸·Î LAMS ÀýÂ÷´Â ÀüÅëÀûÀÎ ½ºÅÙÆ® À¯Ä¡¼úº¸´Ù ºñ½Î°í ´Ù¾çÇÑ ÀÓ»ó ¿¬±¸´Â LAMS¿Í ÀüÅëÀûÀÎ ½ºÅÙÆ® °á°ú¿¡ °ÅÀÇ Â÷À̰¡ ¾øÀ½À» º¸¿©ÁÝ´Ï´Ù.

·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

  • ¼¼°èÀÇ IBD Áõ·Ê Áõ°¡ : ¿°Áõ¼º Àå Áúȯ(IBD)ÀÇ ÀÌȯÀ² Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. IBD´Â Àå°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸¸¼º ÁúȯÀ¸·Î, Å©·Ðº´À̳ª ±Ë¾ç¼º ´ëÀå¿°ÀÌ °¡Àå ÈçÇÑ À¯ÇüÀÔ´Ï´Ù.

IBD¸¦ °ü¸®Çϱâ À§ÇØ, ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ®´Â ¼ºÀÎÀÇ ¼ÒÈ­°ü ÇùÂø¿¡ ´ëóÇÏ´Â È¿°úÀûÀÎ µµ±¸ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÃÖ±Ù¿¡´Â Å©·Ðº´ ȯÀÚ ¼ö°¡ ¼¼°èÀûÀ¸·Î ÇöÀúÇÏ°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. National Center for Biotechnology Information¿¡ µû¸£¸é, 2023³â ÇöÀç ij³ª´Ù¿¡¼­´Â 10¸¸¸í´ç ¾à 825·ÊÀÇ ¿°Áõ¼º Àå ÁúȯÀÌ º¸°íµÇ°í ÀÖÀ¸¸ç, ÇâÈÄ 10³â°£ Áõ°¡À²Àº 2.44%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î Gastroenterology AdvisorÀÇ º¸°í¿¡ µû¸£¸é ¹Ì±¹¿¡¼­ IBDÀÇ À¯º´·üµµ ÇöÀúÇÏ°Ô »ó½ÂÇϰí ÀÖ½À´Ï´Ù. 2023³â ¹Ì±¹ÀÇ IBD ȯÀÚ ¼ö´Â 239¸¸ ¸íÀ¸·Î ÃßÁ¤µÇ¾úÀ¸¸ç, ±× ³»¿ªÀº Å©·Ðº´ÀÌ 101¸¸ ¸í, ±Ë¾ç¼º ´ëÀå¿°ÀÌ 125¸¸ ¸íÀÔ´Ï´Ù. À¯º´·üÀº 10¸¸ ¸í´ç ¾à 721¸íÀÔ´Ï´Ù.

Áö¸®Àû Àü¸Á

  • ºÏ¹Ì°¡ Áö¹èÀûÀÏ °ÍÀ¸·Î ¿¹Ãø : ºÏ¹Ì´Â ¿¹Ãø ±â°£ µ¿¾È ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå¿¡¼­ »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ê Àü¸ÁÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº »ý¸í°øÇаú ÇコÄɾ¼­ °¡Àå Å©°í °¡Àå ±â¼úÀûÀ¸·Î ÁøÇàµÈ Áö¿ª Áß Çϳª·Î Àνĵǰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡´Â ƯÈ÷ ¹Ì±¹°ú ij³ª´Ù¸¦ Áß½ÉÀ¸·Î ÇコÄɾ ¼±µµÇÏ´Â ±â¼ú °³¹ßÀÚ°¡ ¿©·¯ ¸í ÀÖ½À´Ï´Ù.

°Ô´Ù°¡ ÀÇ·á±â¼ú °³Ã´À» °­È­Çϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ÀÌ ±â°£ ½ÃÀå ¼ºÀåÀ» ´õ¿í ²ø¾î¿Ã¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºÏ¹ÌÀÇ ¿°Áõ¼º Àå Áúȯ°ú À§Àå ÁúȯÀÇ À¯º´·ü Áõ°¡µµ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¶»ç¿¡ ÀÇÇϸé, ÀÌ Áö¿ª¿¡¼­´Â IBD³ª À§ÀåÁúȯÀÇ Áõ·Ê°¡ ´Ù¸¥ Áö¿ª¿¡ ºñÇØ ¸¹°í, ±× ÁÖ¿ä ¿øÀÎÀº °íµµ·Î °¡°øµÈ ½ÄǰÀÇ ¼Òºñ Áõ°¡¿Í ½ÄÀ̼¶À¯ÀÇ ¼·Ãë·®ÀÇ °¨¼ÒÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇÏ´Â ÀÌÀ¯

  • ÀλçÀÌÆ® ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦ ¿äÀÎ, ¼ÒºñÀÚ ¼±È£, »ê¾÷º° ¹× ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÁßÁ¡À» µÎ¾î ÁÖ¿ä ¹× ½ÅÈï Áö¿ªÀ» ´Ù·ç´Â »ó¼¼ÇÑ ½ÃÀå °í·Á»çÇ×À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï ±¸µµ : ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«Àû Àü·«À» ÀÌÇØÇϰí ÀûÀýÇÑ Àü·«À¸·Î ½ÃÀå ħÅõ °¡´É¼ºÀ» ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå µ¿Çâ ¹× ÃËÁø¿äÀÎ : µ¿Àû ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í ±×µéÀÌ ÇâÈÄ ½ÃÀå Àü°³¸¦ ¾î¶»°Ô Çü¼ºÇØ ³ª°¡´ÂÁö¸¦ ޱ¸ÇÕ´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ Á¦¾È : ¿ªµ¿ÀûÀΠȯ°æ¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû °áÁ¤À» ³»¸®±â À§ÇØ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
  • Æø³ÐÀº ÀÌ¿ëÀÚ¿¡ ´ëÀÀ : ½ÅÈï±â¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

  • ½ÇÀû µ¥ÀÌÅÍ ¹× ¿¹Ãø(2022-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ Ʋ, °í°´ Çൿ, µ¿Ç⠺м®
  • °æÀï Æ÷Áö¼Å´×, Àü·«, ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¼öÀÍ ¼ºÀå ¹× ¿¹Ãø ±¹°¡¸¦ Æ÷ÇÔÇÑ ºÎ¹® ¹× Áö¿ª ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫 »óȲ, ÁÖ¿ä ¹ßÀü µî)

·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀåÀº ´ÙÀ½°ú °°ÀÌ ¼¼ºÐÈ­µÇ°í ºÐ¼®µË´Ï´Ù.

±â¼úº°

  • ±âÁ¸ LAMS
  • Àü±â ¼ÒÀÛ½Ä LAMS(EC-LAMS)

¿ëµµº°

  • ¾ç¼º ´ãµµ ÇùÂø
  • ¾çÃé ´©Ãâ
  • ÃéÀå¾Ï
  • ±âŸ

ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Áö¿ªº°

  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ³²¹Ì
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ
  • À¯·´
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • UAE
  • À̽º¶ó¿¤
  • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ÀϺ»
  • Áß±¹
  • Àεµ
  • Çѱ¹
  • Àεµ³×½Ã¾Æ
  • ű¹
  • ´ë¸¸
  • ±âŸ

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­
  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ ¹× ¿¹Ãø¿¬µµÀÇ Å¸ÀÓ¶óÀÎ
  • ÀÌÇØ °ü°èÀÚ¿¡°Ô À־ ÁÖ¿ä ÀÌÁ¡

Á¦2Àå Á¶»ç ¹æ¹ý

  • Á¶»ç µðÀÚÀÎ
  • Á¶»ç °úÁ¤

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä Á¶»ç °á°ú

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • ¾Ö³Î¸®½ºÆ® º¸±â

Á¦5Àå ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå : ±â¼úº°

  • ¼­¹®
  • ±âÁ¸ LAMS
  • Àü±â ¼ÒÀÛ½Ä LAMS(EC-LAMS)

Á¦6Àå ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå : ¿ëµµº°

  • ¼­¹®
  • ¾ç¼º ´ãµµ ÇùÂø
  • ´ãÃé ´©Ãâ
  • ÃéÀå¾Ï
  • ±âŸ

Á¦7Àå ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼­¹®
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ·ç¸à ¾îÆ÷¡ ±Ý¼Ó ½ºÅÙÆ® ½ÃÀå : Áö¿ªº°

  • ¼­¹®
  • ºÏ¹Ì
    • ±â¼úº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • ³²¹Ì
    • ±â¼úº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • À¯·´
    • ±â¼úº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±â¼úº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±â¼úº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ±¹°¡º°

Á¦9Àå °æÀï ȯ°æ ¹× ºÐ¼®

  • ÁÖ¿ä ±â¾÷ ¹× Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÇÕº´, Àμö, ÇÕÀÇ ¹× Äݶ󺸷¹À̼Ç
  • °æÀï ´ë½Ãº¸µå

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Boston Scientific Corporation
  • Mitra Industries
  • ITPL Medical
  • Olympus America
  • Duomed
AJY 25.03.14

The lumen apposing metal stent market is estimated at US$3.678 billion in 2025, and is expected to grow at a CAGR of 5.12%, attaining US$4.720 billion by 2030.

A lumen-apposing metal stent (LAMS) is a specialized device designed to enhance the scope of endoscopic interventions. Characterized by a dumbbell configuration and short saddle length, LAMS are specifically engineered to drain pancreatic fluid collections (PFCs) and address various gastrointestinal diseases. These stents offer significant advantages over traditional stents, particularly in terms of drainage efficiency, making them especially useful for conditions like walled-off necrosis. Additionally, LAMS have a reduced risk of migration and minimize the need for invasive procedures.The global market for lumen-apposing metal stents is expected to see substantial growth during the forecast period, primarily driven by the increasing incidence of inflammatory bowel diseases (IBD) worldwide. LAMS play a crucial role in managing IBD, particularly in cases of Crohn's disease, by providing effective monitoring and treatment options. The rising prevalence of gastrointestinal disorders is also anticipated to contribute to market growth.However, the expansion of the lumen-apposing metal stent market may face challenges due to the potential for side effects and the higher costs associated with these procedures. Generally, LAMS procedures are more expensive than traditional stent placements, and various clinical studies have shown minimal differences in outcomes between LAMS and conventional stents.

Drivers of the Lumen-Apposing Metal Stent Market

  • Increasing Global Cases of IBD: The rising incidence of inflammatory bowel disease (IBD) is expected to significantly drive the growth of the lumen-apposing metal stent market during the forecast period. IBD is a chronic condition affecting the intestinal tract, with Crohn's disease and ulcerative colitis being among the most common types.

In managing IBD, lumen-apposing metal stents serve as an effective tool for addressing luminal gastrointestinal strictures in adults. Recent years have seen a notable increase in global cases of Crohn's disease. According to the National Center for Biotechnology Information, as of 2023, Canada reported approximately 825 cases of inflammatory bowel diseases per 100,000 individuals, with projections indicating a growth rate of 2.44% over the next decade. The total number of IBD cases in Canada is estimated to be around 320,000.Similarly, a report from Gastroenterology Advisor indicated that the prevalence of IBD in the USA has also risen significantly. In 2023, there were an estimated 2.39 million cases of IBD in the USA, including about 1.01 million cases of Crohn's disease and 1.25 million cases of ulcerative colitis. The prevalence rate was recorded at approximately 721 per 100,000 individuals in the USA.

Geographical Outlook

  • North America Expected to Dominate: The North American region is poised for substantial growth in the lumen-apposing metal stent market during the forecast period. This region is recognized as one of the largest and most technologically advanced areas within biotechnology and healthcare. It hosts several leading technological developers in healthcare, particularly in the United States and Canada.

Additionally, government initiatives aimed at enhancing technological development in healthcare are expected to further boost market growth during this time frame. The increasing prevalence of inflammatory bowel disorders and gastrointestinal diseases in North America is also anticipated to drive market expansion. Research indicates that cases of IBD and gastrointestinal diseases are higher in this region compared to others, largely due to increased consumption of highly processed foods and lower fiber intake.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Lumen Apposing Metal Stent Market is segmented and analyzed as:

By Technology

  • Traditional LAMS
  • Electro-cautery LAMS (EC-LAMS)

By Application

  • Benign Biliary Strictures
  • Bilo-Pancreatic Leakages
  • Pancreatic Cancer
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific Region
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. LUMEN APPOSING METAL STENT MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Traditional LAMS
  • 5.3. Electro-cautery LAMS (EC-LAMS)

6. LUMEN APPOSING METAL STENT MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Benign Biliary Strictures
  • 6.3. Bilo-Pancreatic Leakages
  • 6.4. Pancreatic Cancer
  • 6.5. Others

7. LUMEN APPOSING METAL STENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. LUMEN APPOSING METAL STENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Saudi Arabia
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Mitra Industries
  • 10.3. ITPL Medical
  • 10.4. Olympus America
  • 10.5. Duomed
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦